 Kathryn Chatfield
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Noonan Syndrome | 5 | 2022 | 14 | 2.380 |
Why?
| | Cardiolipins | 4 | 2025 | 84 | 1.420 |
Why?
| | Cardiomyopathies | 7 | 2025 | 325 | 1.390 |
Why?
| | Barth Syndrome | 2 | 2021 | 8 | 0.900 |
Why?
| | Heart Transplantation | 3 | 2019 | 709 | 0.850 |
Why?
| | Electron Transport Complex I | 2 | 2021 | 41 | 0.850 |
Why?
| | Myocardium | 6 | 2025 | 921 | 0.800 |
Why?
| | Williams Syndrome | 2 | 2021 | 13 | 0.750 |
Why?
| | Mitochondria, Heart | 3 | 2020 | 101 | 0.720 |
Why?
| | Turner Syndrome | 4 | 2025 | 55 | 0.700 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2021 | 17 | 0.690 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 2025 | 18 | 0.680 |
Why?
| | Fatty Acids | 3 | 2025 | 444 | 0.660 |
Why?
| | General Practice | 1 | 2019 | 30 | 0.610 |
Why?
| | Cardiomyopathy, Hypertrophic | 4 | 2023 | 140 | 0.610 |
Why?
| | Heart Defects, Congenital | 5 | 2025 | 863 | 0.580 |
Why?
| | Alagille Syndrome | 1 | 2018 | 28 | 0.580 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 73 | 0.570 |
Why?
| | DNA, Mitochondrial | 2 | 2020 | 208 | 0.550 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2023 | 334 | 0.510 |
Why?
| | Costello Syndrome | 3 | 2023 | 3 | 0.510 |
Why?
| | Mutation | 9 | 2022 | 3987 | 0.500 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.450 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.450 |
Why?
| | ras Proteins | 4 | 2022 | 148 | 0.440 |
Why?
| | Heart Failure | 2 | 2019 | 2067 | 0.420 |
Why?
| | Heart Ventricles | 2 | 2020 | 746 | 0.420 |
Why?
| | Mitochondria | 2 | 2021 | 955 | 0.400 |
Why?
| | De Lange Syndrome | 1 | 2012 | 2 | 0.390 |
Why?
| | Infant | 12 | 2024 | 9574 | 0.370 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2021 | 22 | 0.370 |
Why?
| | Pyrimidinones | 2 | 2023 | 114 | 0.360 |
Why?
| | Pyridones | 2 | 2023 | 170 | 0.340 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 46 | 0.340 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2152 | 0.340 |
Why?
| | Genetic Association Studies | 1 | 2012 | 370 | 0.330 |
Why?
| | Mydriasis | 2 | 2022 | 10 | 0.330 |
Why?
| | Child | 16 | 2024 | 21921 | 0.310 |
Why?
| | Child, Preschool | 8 | 2021 | 11158 | 0.310 |
Why?
| | Energy Metabolism | 1 | 2015 | 922 | 0.300 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1470 | 0.280 |
Why?
| | Chromosome Disorders | 2 | 2021 | 43 | 0.280 |
Why?
| | Acyltransferases | 3 | 2025 | 56 | 0.280 |
Why?
| | Humans | 38 | 2025 | 138651 | 0.270 |
Why?
| | Phenotype | 4 | 2021 | 3139 | 0.250 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 2030 | 0.250 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 1 | 2025 | 3 | 0.230 |
Why?
| | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase | 1 | 2025 | 3 | 0.230 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2025 | 5 | 0.230 |
Why?
| | Purpura | 1 | 2025 | 17 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 132 | 0.230 |
Why?
| | Female | 22 | 2025 | 73763 | 0.230 |
Why?
| | Heart Valve Diseases | 2 | 2024 | 153 | 0.230 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2022 | 43 | 0.220 |
Why?
| | Male | 19 | 2025 | 68260 | 0.220 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.220 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.220 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 28 | 0.210 |
Why?
| | Niacinamide | 1 | 2024 | 82 | 0.210 |
Why?
| | Aortic Valve | 2 | 2024 | 358 | 0.200 |
Why?
| | Ectodermal Dysplasia | 1 | 2022 | 18 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 2019 | 44 | 0.190 |
Why?
| | Regional Blood Flow | 1 | 2024 | 496 | 0.190 |
Why?
| | Stress, Mechanical | 1 | 2024 | 487 | 0.190 |
Why?
| | Face | 2 | 2020 | 173 | 0.180 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 109 | 0.180 |
Why?
| | Hemodynamics | 2 | 2024 | 1093 | 0.180 |
Why?
| | Gene Expression | 3 | 2018 | 1488 | 0.180 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 215 | 0.170 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 8 | 0.170 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 12 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2022 | 177 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 262 | 0.170 |
Why?
| | Anesthetics | 1 | 2022 | 98 | 0.170 |
Why?
| | Genetic Testing | 2 | 2021 | 451 | 0.170 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 1076 | 0.170 |
Why?
| | Infant, Newborn | 7 | 2018 | 6144 | 0.170 |
Why?
| | Coenzyme A | 1 | 2020 | 7 | 0.170 |
Why?
| | Aorta | 2 | 2024 | 418 | 0.170 |
Why?
| | Urinary Bladder | 1 | 2022 | 187 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 74 | 0.160 |
Why?
| | Biological Products | 1 | 2023 | 231 | 0.160 |
Why?
| | Echocardiography | 2 | 2024 | 640 | 0.160 |
Why?
| | Actins | 2 | 2022 | 419 | 0.160 |
Why?
| | Liver Diseases | 1 | 2022 | 289 | 0.150 |
Why?
| | Genes, ras | 1 | 2019 | 94 | 0.150 |
Why?
| | Electron Transport | 2 | 2020 | 116 | 0.150 |
Why?
| | Intellectual Disability | 1 | 2021 | 168 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 285 | 0.150 |
Why?
| | Calcium | 2 | 2022 | 1180 | 0.150 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.150 |
Why?
| | Nitrogenous Group Transferases | 1 | 2018 | 2 | 0.150 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2018 | 17 | 0.150 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2018 | 4 | 0.150 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 16 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2018 | 43 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 364 | 0.140 |
Why?
| | Postoperative Period | 1 | 2019 | 355 | 0.140 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 13 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 248 | 0.140 |
Why?
| | Mitochondrial Diseases | 1 | 2018 | 91 | 0.140 |
Why?
| | Protein Subunits | 1 | 2018 | 229 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 257 | 0.140 |
Why?
| | Constriction, Pathologic | 1 | 2018 | 237 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 196 | 0.130 |
Why?
| | Seizures | 1 | 2021 | 431 | 0.130 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 52 | 0.130 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 10 | 0.130 |
Why?
| | Adolescent | 7 | 2024 | 21564 | 0.130 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 18 | 0.130 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 188 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2021 | 3523 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 513 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 564 | 0.120 |
Why?
| | Muscle, Smooth | 3 | 2022 | 151 | 0.120 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2018 | 136 | 0.120 |
Why?
| | Retrospective Studies | 4 | 2024 | 15909 | 0.120 |
Why?
| | Genetic Diseases, Inborn | 1 | 2016 | 45 | 0.120 |
Why?
| | Emotions | 1 | 2021 | 568 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 30 | 0.120 |
Why?
| | Heart | 1 | 2019 | 611 | 0.120 |
Why?
| | Dyskinesias | 1 | 2015 | 20 | 0.110 |
Why?
| | Cell Respiration | 1 | 2015 | 103 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2016 | 316 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1656 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 91 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2727 | 0.110 |
Why?
| | Vascular Stiffness | 1 | 2018 | 443 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 332 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2339 | 0.100 |
Why?
| | Fibroblasts | 2 | 2018 | 1003 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 1992 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2025 | 2053 | 0.100 |
Why?
| | Chondroitin Sulfate Proteoglycans | 1 | 2012 | 10 | 0.100 |
Why?
| | Age Factors | 2 | 2024 | 3256 | 0.100 |
Why?
| | Parents | 1 | 2021 | 1421 | 0.090 |
Why?
| | Genotype | 2 | 2019 | 1842 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1746 | 0.090 |
Why?
| | Transcription Factors | 1 | 2020 | 1697 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2020 | 2815 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 258 | 0.090 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 124 | 0.090 |
Why?
| | Registries | 1 | 2019 | 2073 | 0.090 |
Why?
| | Signal Transduction | 3 | 2023 | 5086 | 0.080 |
Why?
| | Syndrome | 2 | 2022 | 377 | 0.080 |
Why?
| | Genomics | 1 | 2014 | 796 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 616 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 5803 | 0.070 |
Why?
| | Disease Management | 2 | 2025 | 622 | 0.070 |
Why?
| | Developmental Disabilities | 2 | 2021 | 268 | 0.070 |
Why?
| | Pregnancy | 2 | 2018 | 6829 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1006 | 0.060 |
Why?
| | Liver | 1 | 2015 | 1805 | 0.060 |
Why?
| | Mice | 5 | 2025 | 17814 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2025 | 9 | 0.060 |
Why?
| | Rhabdomyolysis | 1 | 2025 | 24 | 0.060 |
Why?
| | Dilatation, Pathologic | 1 | 2024 | 60 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2019 | 10923 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2851 | 0.050 |
Why?
| | Perfusion Imaging | 1 | 2024 | 62 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 70 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 21 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2024 | 197 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 346 | 0.050 |
Why?
| | Blood Flow Velocity | 1 | 2024 | 411 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2022 | 28 | 0.050 |
Why?
| | Duodenum | 1 | 2022 | 74 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2876 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2024 | 272 | 0.050 |
Why?
| | Disulfides | 1 | 2022 | 97 | 0.050 |
Why?
| | Nervous System Diseases | 1 | 2025 | 273 | 0.050 |
Why?
| | United States | 1 | 2019 | 14938 | 0.050 |
Why?
| | Calcium Channels | 1 | 2022 | 156 | 0.040 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 9 | 0.040 |
Why?
| | Animals | 5 | 2025 | 37217 | 0.040 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2021 | 36 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.040 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 53 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 309 | 0.040 |
Why?
| | Myofibrils | 1 | 2021 | 48 | 0.040 |
Why?
| | Sarcomeres | 1 | 2021 | 93 | 0.040 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 222 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2021 | 113 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 163 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 278 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 489 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13305 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 624 | 0.040 |
Why?
| | SOS1 Protein | 1 | 2018 | 2 | 0.040 |
Why?
| | LEOPARD Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2020 | 331 | 0.040 |
Why?
| | Lentivirus | 1 | 2018 | 59 | 0.040 |
Why?
| | Amiodarone | 1 | 2018 | 27 | 0.040 |
Why?
| | Digoxin | 1 | 2018 | 26 | 0.040 |
Why?
| | Propranolol | 1 | 2018 | 45 | 0.040 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1109 | 0.040 |
Why?
| | Adult | 3 | 2018 | 38201 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 166 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 448 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2023 | 2172 | 0.040 |
Why?
| | Lactoferrin | 1 | 1998 | 40 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 194 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2018 | 139 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1110 | 0.030 |
Why?
| | Pedigree | 1 | 2018 | 511 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 272 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 180 | 0.030 |
Why?
| | Milk | 1 | 1998 | 123 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 1998 | 130 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1567 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 502 | 0.030 |
Why?
| | Capital Financing | 1 | 2016 | 8 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 261 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 276 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 873 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 59 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2018 | 434 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 329 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
| | Leigh Disease | 1 | 2015 | 22 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1238 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 540 | 0.030 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2014 | 20 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2014 | 34 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4315 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 916 | 0.030 |
Why?
| | Aged | 1 | 2014 | 24024 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 2155 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 305 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 553 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1742 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1806 | 0.030 |
Why?
| | Models, Molecular | 1 | 2018 | 1587 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 4181 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2020 | 3028 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5520 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4092 | 0.020 |
Why?
| | Middle Aged | 1 | 2014 | 33604 | 0.020 |
Why?
| | Mental Disorders | 1 | 2021 | 1096 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5697 | 0.020 |
Why?
| | Family | 1 | 2016 | 677 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2016 | 1034 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2235 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2590 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3637 | 0.020 |
Why?
| | Lactation | 1 | 1998 | 174 | 0.010 |
Why?
| | Iron | 1 | 1998 | 323 | 0.010 |
Why?
|
|
Chatfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|